BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35466171)

  • 21. Biopsy-proven case of Epstein-Barr virus (EBV)-associated vasculitis of the central nervous system.
    Kano K; Katayama T; Takeguchi S; Asanome A; Takahashi K; Saito T; Sawada J; Saito M; Anei R; Kamada K; Miyokawa N; Nishihara H; Hasebe N
    Neuropathology; 2017 Jun; 37(3):259-264. PubMed ID: 28004435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus and rheumatoid arthritis.
    Balandraud N; Roudier J; Roudier C
    Autoimmun Rev; 2004 Jul; 3(5):362-7. PubMed ID: 15288002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection.
    Miyazaki T; Fujimaki K; Shirasugi Y; Yoshiba F; Ohsaka M; Miyazaki K; Yamazaki E; Sakai R; Tamaru J; Kishi K; Kanamori H; Higashihara M; Hotta T; Ishigatsubo Y
    Am J Hematol; 2007 Dec; 82(12):1106-9. PubMed ID: 17654684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial.
    Araujo CSR; Medeiros-Ribeiro AC; Saad CGS; Bonfiglioli KR; Domiciano DS; Shimabuco AY; Silva MSR; Yuki EFN; Pasoto SG; Pedrosa T; Kupa LVK; Zou G; Pereira RMR; Silva CA; Aikawa NE; Bonfa E
    Ann Rheum Dis; 2022 Jun; 81(6):889-897. PubMed ID: 35193873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update.
    Toussirot E; Roudier J
    Joint Bone Spine; 2007 Oct; 74(5):418-26. PubMed ID: 17625943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute gastrointestinal graft-versus-host disease with cytomegalovirus and Epstein-Barr virus superinfection in a patient with COVID-19.
    Dias E; Marques M; Lopes S; Gullo I; Bastos J; Macedo G
    Rev Esp Enferm Dig; 2023 Feb; 115(2):92-93. PubMed ID: 35748474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
    Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
    J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-SARS-CoV-2 mRNA vaccines as inducers of humoral response against apolipoprotein A-1?
    Vuilleumier N; Pagano S; Ludewig B; Schmiedeberg K; Haller C; von Kempis J; Rubbert-Roth A
    Eur J Clin Invest; 2022 Feb; 52(2):e13713. PubMed ID: 34841527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis.
    Mourgues C; Henquell C; Tatar Z; Pereira B; Nourisson C; Tournadre A; Soubrier M; Couderc M
    Joint Bone Spine; 2016 Jul; 83(4):412-5. PubMed ID: 26725744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus and rheumatoid arthritis.
    Balandraud N; Roudier J
    Joint Bone Spine; 2018 Mar; 85(2):165-170. PubMed ID: 28499895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Search for correlation of CD8 T cell response to Epstein-Barr virus with clinical status in rheumatoid arthritis: a 15 month followup pilot study.
    Berthelot JM; Saulquin X; Coste-Burel M; Peyrat MA; Echasserieau K; Bonneville M; Houssaint E
    J Rheumatol; 2003 Aug; 30(8):1673-9. PubMed ID: 12913921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
    Guo J; Cui Z; Zheng Y; Li X; Chen Y
    Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus-associated B-cell type non-Hodgkin's lymphoma with concurrent p53 protein expression in a rheumatoid arthritis patient treated with methotrexate.
    Hirose Y; Masaki Y; Okada J; Kim CG; Kawabata H; Ogawa N; Wano Y; Sugai S
    Int J Hematol; 2002 May; 75(4):412-5. PubMed ID: 12041674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
    Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isotypes of Epstein-Barr virus antibodies in rheumatoid arthritis: association with rheumatoid factors and citrulline-dependent antibodies.
    Westergaard MW; Draborg AH; Troelsen L; Jacobsen S; Houen G
    Biomed Res Int; 2015; 2015():472174. PubMed ID: 26000294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr Virus Coinfection in COVID-19.
    Nadeem A; Suresh K; Awais H; Waseem S
    J Investig Med High Impact Case Rep; 2021; 9():23247096211040626. PubMed ID: 34428954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Status and Prospects of Epstein-Barr Virus Prophylactic Vaccine Development.
    Sun C; Chen XC; Kang YF; Zeng MS
    Front Immunol; 2021; 12():677027. PubMed ID: 34168649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
    Verma D; Church TM; Swaminathan S
    J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Epstein-Barr Virus DNA on the Incidence and Severity of Arthritis in a Rheumatoid Arthritis Mouse Model.
    Fadlallah S; Hussein H; Jallad MA; Shehab M; Jurjus AR; Matar GM; Rahal EA
    Front Immunol; 2021; 12():672752. PubMed ID: 34040613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses.
    Saleem B; Ross RL; Bissell LA; Aslam A; Mankia K; Duquenne L; Corsadden D; Carter C; Hughes P; Nadat FA; Mulipa P; Lobb M; Clarke B; Mbara K; Morton R; Dibb S; Chowdhury R; Newton D; Pike A; Kakkar V; Savic S; DelGaldo F; Emery P
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35365569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.